Tianjin Chase Sun Pharmaceutical Co.,Ltd (SHE: 300026)
China
· Delayed Price · Currency is CNY 3.200
-0.010 (-0.31%)
Sep 9, 2024, 1:48 PM CST
Tianjin Chase Sun Pharmaceutical Co.,Ltd Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Operating Revenue | 5,610 | 6,025 | 6,603 | 7,656 | 6,463 | 4,983 | Upgrade
|
| Other Revenue | 71.77 | 84.31 | 47.44 | 14.63 | 25.37 | 20.05 | Upgrade
|
| Revenue | 5,682 | 6,109 | 6,650 | 7,671 | 6,488 | 5,003 | Upgrade
|
| Revenue Growth (YoY) | -15.98% | -8.14% | -13.30% | 18.22% | 29.69% | 18.44% | Upgrade
|
| Cost of Revenue | 2,769 | 2,827 | 2,826 | 3,267 | 2,858 | 1,650 | Upgrade
|
| Gross Profit | 2,912 | 3,282 | 3,824 | 4,403 | 3,630 | 3,353 | Upgrade
|
| Selling, General & Admin | 2,295 | 2,463 | 2,751 | 3,054 | 2,648 | 2,507 | Upgrade
|
| Research & Development | 202.71 | 209.81 | 230.85 | 196.59 | 177.03 | 178.81 | Upgrade
|
| Other Operating Expenses | 59.16 | 41.4 | 61.72 | 76.44 | 1.87 | 60.14 | Upgrade
|
| Operating Expenses | 2,652 | 2,767 | 3,100 | 3,401 | 2,896 | 2,773 | Upgrade
|
| Operating Income | 260.53 | 515.52 | 724.42 | 1,002 | 733.98 | 579.58 | Upgrade
|
| Interest Expense | -56.57 | -61.57 | -69.67 | -50.1 | -30.07 | -10.77 | Upgrade
|
| Interest & Investment Income | 20.99 | 19.31 | 14.18 | 11.38 | 12.03 | 29.92 | Upgrade
|
| Earnings From Equity Investments | -0.39 | - | - | - | - | - | Upgrade
|
| Currency Exchange Gain (Loss) | 0.75 | 2.41 | 17.62 | -6.34 | -29.34 | 1.57 | Upgrade
|
| Other Non Operating Income (Expenses) | -25.64 | -18.49 | -35.65 | -26.86 | 21.11 | -10.62 | Upgrade
|
| EBT Excluding Unusual Items | 199.66 | 457.19 | 650.91 | 930.58 | 707.71 | 589.69 | Upgrade
|
| Impairment of Goodwill | -23.52 | -23.52 | - | -58.18 | - | -120.33 | Upgrade
|
| Gain (Loss) on Sale of Investments | -1.4 | -1.4 | - | -22.98 | - | - | Upgrade
|
| Gain (Loss) on Sale of Assets | 1.69 | 1.06 | 0.01 | -2.87 | 0.03 | 0.01 | Upgrade
|
| Asset Writedown | -3.47 | -4.05 | -2.36 | -9.35 | -24.3 | -11.74 | Upgrade
|
| Legal Settlements | - | - | - | - | - | -13.49 | Upgrade
|
| Other Unusual Items | 195.62 | 177.54 | 67.82 | 16.99 | -0.03 | 40.3 | Upgrade
|
| Pretax Income | 368.59 | 606.82 | 716.37 | 854.18 | 683.41 | 484.44 | Upgrade
|
| Income Tax Expense | 64.14 | 105.25 | 95.14 | 183.32 | 123.73 | 76 | Upgrade
|
| Earnings From Continuing Operations | 304.45 | 501.57 | 621.23 | 670.85 | 559.68 | 408.43 | Upgrade
|
| Minority Interest in Earnings | 4.54 | 5.06 | 3.01 | 16.47 | 13.71 | -5.9 | Upgrade
|
| Net Income | 308.99 | 506.63 | 624.24 | 687.32 | 573.39 | 402.53 | Upgrade
|
| Net Income to Common | 308.99 | 506.63 | 624.24 | 687.32 | 573.39 | 402.53 | Upgrade
|
| Net Income Growth | -49.96% | -18.84% | -9.18% | 19.87% | 42.45% | 90.96% | Upgrade
|
| Shares Outstanding (Basic) | 3,021 | 2,980 | 2,973 | 2,988 | 3,018 | 2,875 | Upgrade
|
| Shares Outstanding (Diluted) | 3,021 | 2,980 | 2,973 | 2,988 | 3,018 | 2,875 | Upgrade
|
| Shares Change (YoY) | 2.62% | 0.26% | -0.53% | -0.98% | 4.96% | -4.52% | Upgrade
|
| EPS (Basic) | 0.10 | 0.17 | 0.21 | 0.23 | 0.19 | 0.14 | Upgrade
|
| EPS (Diluted) | 0.10 | 0.17 | 0.21 | 0.23 | 0.19 | 0.14 | Upgrade
|
| EPS Growth | -51.23% | -19.05% | -8.70% | 21.05% | 35.71% | 100.00% | Upgrade
|
| Free Cash Flow | 1,102 | 1,183 | -24.93 | -285.85 | -367.12 | -374.91 | Upgrade
|
| Free Cash Flow Per Share | 0.36 | 0.40 | -0.01 | -0.10 | -0.12 | -0.13 | Upgrade
|
| Dividend Per Share | 0.030 | 0.030 | 0.030 | 0.040 | 0.040 | 0.050 | Upgrade
|
| Dividend Growth | 0% | 0% | -25.00% | 0% | -20.00% | 150.00% | Upgrade
|
| Gross Margin | 51.26% | 53.73% | 57.50% | 57.40% | 55.95% | 67.02% | Upgrade
|
| Operating Margin | 4.59% | 8.44% | 10.89% | 13.07% | 11.31% | 11.58% | Upgrade
|
| Profit Margin | 5.44% | 8.29% | 9.39% | 8.96% | 8.84% | 8.05% | Upgrade
|
| Free Cash Flow Margin | 19.39% | 19.36% | -0.37% | -3.73% | -5.66% | -7.49% | Upgrade
|
| EBITDA | 541.18 | 797.57 | 974.09 | 1,217 | 923.97 | 735.75 | Upgrade
|
| EBITDA Margin | 9.53% | 13.06% | 14.65% | 15.86% | 14.24% | 14.71% | Upgrade
|
| D&A For EBITDA | 280.65 | 282.04 | 249.67 | 214.2 | 189.99 | 156.18 | Upgrade
|
| EBIT | 260.53 | 515.52 | 724.42 | 1,002 | 733.98 | 579.58 | Upgrade
|
| EBIT Margin | 4.59% | 8.44% | 10.89% | 13.07% | 11.31% | 11.58% | Upgrade
|
| Effective Tax Rate | 17.40% | 17.35% | 13.28% | 21.46% | 18.11% | 15.69% | Upgrade
|
| Revenue as Reported | 6,109 | 6,109 | 6,650 | 7,671 | 6,488 | 5,003 | Upgrade
|
| Advertising Expenses | - | 9.15 | 12.6 | 21.21 | 19.45 | 16.39 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.